Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06861361 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients

Study acronym: START YOUNG
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 2027 to Sep 2028v3 Show 4 more changesShow less
    • Study sites: 7 to 49
    • Study completion date: Nov 2031 to Sep 2037
    • Secondary endpoints: details revised at 7 of 23 entries
    • Collaborators expanded, about 4 words
  2. Trial status: Not Yet Recruiting to Recruitingv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ceric Sàrl
10 trials monitored
See 1 trial at risk
The study objective is to demonstrate that the clinical outcomes of the Myval balloon-expandable THV series are non-inferior to those of SAVR in patients with symptomatic severe aortic stenosis aged 65 to 75 years.
Trial Details
NCT Number NCT06861361
Lead Sponsor Ceric Sàrl
Collaborators: European Cardiovascular Research Center
Conditions
(from sponsor)		 Symptomatic Severe Aortic Stenosis
Enrollment 1,180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov